InspireMD
NSPR
0 hedge funds and large institutions have $516K invested in InspireMD in 2015 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
76% less capital invested
Capital invested by funds: $2.17M → $516K (-$1.66M)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.07M |
| 2 |
Jennison Associates
New York
|
-$265K |
| 3 |
Goldman Sachs
New York
|
-$9K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$4K |
| 5 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$3K |
NSPR Hedge Fund Activity: Q4 2015 in Review
0 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2015, worth a combined $516K — down 76% from $2.17M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NSPR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Armistice Capital, exiting entirely with an estimated $1.07M sold.
- 0 institutional investors held InspireMD (NSPR) as of Q4 2015, down from 1 in Q3 2015.
- Funds reported $516K of InspireMD stock for Q4 2015, down 76% quarter-over-quarter.
- 0 funds opened new InspireMD positions in Q4 2015 and 1 closed out, a net change of -1 holder.
- The largest InspireMD seller in Q4 2015 was Armistice Capital, an estimated $1.07M sold.
Based on aggregated 13F filings for Q4 2015.